Ca2+ enhancement of hemolysis induced by the topical anesthetic oxethazaine in vitro.
R Yasuno, T Oguma, Y Masuda
Index: Biol. Pharm. Bull. 21(12) , 1294-9, (1998)
Full Text: HTML
Abstract
Oxethazaine (OXZ), a potent topical anesthetic, was found to induce red blood cell (RBC) lysis in vitro, depending upon concentrations of OXZ, RBC and Ca2+. In a 2% RBC suspension, 100 microM OXZ caused almost complete hemolysis in the presence of 1.3 mM Ca2+ with only a minimal effect in its absence, while higher concentrations of OXZ (400 microM<) produced hemolysis without Ca2+. The hemolysis induced by OXZ plus Ca2+ was preceded by a rapid increase in 45Ca2+ uptake by RBCs, with both the hemolysis and Ca2+ uptake being inhibited by 1 mM CoCl2, NiCl2, and quinine. Together with the Ca2+ influx, rapid influx of Na+ and efflux of K+ occurred, and an increasing external K+/Na+ concentration ratio inhibited both hemolysis and Ca2+ influx. Morphologically, OXZ plus Ca2+ caused rapid transformation to spheroechinocytes, the formation of blebs and the pinching-off of blebs, whereas OXZ alone produced membrane invagination. SDS-PAGE analysis of the ghosts prepared from the RBCs treated with OXZ plus Ca2+ revealed derangement of cytoskeletal components. OXZ is a rare drug that exhibits a Ca2+ ionophore-like action, increasing the Ca2+ permeability of plasma membranes.
Related Compounds
Related Articles:
2009-01-01
[Forensic Sci. Int. 185(1-3) , e1-5, (2009)]
2010-03-01
[J. Anal. Toxicol. 34(2) , 73-7, (2010)]
1986-01-01
[Curr. Med. Res. Opin. 10(2) , 128-34, (1986)]
2006-03-01
[J. Pharmacol. Sci. 100(3) , 167-74, (2006)]
1988-01-01
[Therapie. 43(1) , 15-9, (1988)]